Karl-Friedrich Kowalewski (@kfkowalewski) 's Twitter Profile
Karl-Friedrich Kowalewski

@kfkowalewski

Attending Urologist @UMM_Urology and Head of Junior research group -Intelligent Systems and Robotis in Urology- @DKFZ | Member @EAU_YAUroTech

ID: 734695152854392832

calendar_today23-05-2016 10:39:09

211 Tweet

380 Followers

362 Following

Tom Powles (@tompowles1) 's Twitter Profile Photo

With Matt Galsky #EAU24 adjuvant nivolumab in bladder ca: HR 0.76 in ITT & 0.56 in PD-L1 +ve. Clinically meaningful results especially in PD-L1 +ves. No data on PD-L1-ve! OS is not yet significant but this data is impressive. ~60% relapse and 24% get subsequent IO. ~10% ⬆️tox.

With <a href="/MattGalsky/">Matt Galsky</a> #EAU24 adjuvant nivolumab in bladder ca: HR 0.76 in ITT &amp; 0.56 in PD-L1 +ve. Clinically meaningful results especially in PD-L1 +ves. No data on PD-L1-ve! OS is not yet significant but this data is impressive. ~60% relapse and 24% get subsequent IO. ~10% ⬆️tox.
Michael Hofman (@drmhofman) 's Twitter Profile Photo

ENZA-P in The Lancet Oncology Lu-177 PSMA-617 + enzalutamide vs. enza alone: ● ↑PFS: 13.0 vs 7.8, hazard radio 0.43 ● PSA90 response 78% vs 37% ● PSA50 response 93% vs. 68% ● no additional side effects Incredible work from Louise Emmett Ian Davis & ANZUP team

ENZA-P in <a href="/TheLancetOncol/">The Lancet Oncology</a> 

Lu-177 PSMA-617 + enzalutamide vs. enza alone: 

● ↑PFS: 13.0 vs 7.8, hazard radio 0.43
● PSA90 response 78% vs 37%
● PSA50 response 93% vs. 68%
● no additional side effects

Incredible work from <a href="/drlouiseemmett/">Louise Emmett</a> <a href="/Prof_IanD/">Ian Davis</a> &amp; <a href="/ANZUPtrials/">ANZUP</a> team
European Urology (@euplatinum) 's Twitter Profile Photo

Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer Read the full article here: buff.ly/3QTtJet @aherlema Matt Cooperberg #UroSoMe #Medtwitter #PCa

Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer

Read the full article here: buff.ly/3QTtJet 

@aherlema <a href="/dr_coops/">Matt Cooperberg</a>

#UroSoMe #Medtwitter #PCa
Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 (@cacciamani_md) 's Twitter Profile Photo

#MachineLearning enables automated screening for systematic reviews and meta-analysis 📊Models optimized for sensitivity. ⏲️Training time ranged between 251-5834 s. 🔍Weighting approach performed best. 📉Misses of relevant studies were mostly zero. #ML #MA #Urology #Pub2Post

#MachineLearning enables automated screening for systematic reviews and meta-analysis 

📊Models optimized for sensitivity.
⏲️Training time ranged between 251-5834 s.
🔍Weighting approach performed best.
📉Misses of relevant studies were mostly zero.

#ML #MA #Urology #Pub2Post
Urology University Center Mannheim (@umm_urology) 's Twitter Profile Photo

Die molekularen Mechanismen von Blasenkrebs verstehen. Grundlagenforschung für Patienten erklärt. Eine Kooperation zwischen Urology University Center Mannheim und DKFZ Epigenetics, gefördert vom Hector Seed Funding Programm! Dank an ⁦Malin Nientiedt⁩ ⁦Manuel NManuel Rodríguez Paredes @filmhochdrei

Enrico Checcucci (@enricocheccucci) 's Twitter Profile Photo

📢 #Metaverse in surgery is a reality! Great #teamwork within EAU Young Academics Urologist. Uro-Tech group 🦾 #AI 👓#3D models 📝surgical planning ⚓️intraoperative navigation 🌍teleconsultation Nature Reviews Urology 👉 rdcu.be/dVBYa

📢 #Metaverse in surgery is a reality!
Great #teamwork within <a href="/EAU_YAUroTech/">EAU Young Academics Urologist. Uro-Tech group</a> 

🦾 #AI 
👓#3D models
📝surgical planning
⚓️intraoperative navigation
🌍teleconsultation

<a href="/NatRevUrol/">Nature Reviews Urology</a> 

👉 rdcu.be/dVBYa
European Urology (@euplatinum) 's Twitter Profile Photo

Platinum Priority - Prostate Cancer: Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer:

Platinum Priority - Prostate Cancer: Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer:
Félix Guerrero-Ramos (@drfelixguerrero) 's Twitter Profile Photo

⚠️For the 1st time in almost 50 years something shows superiority to #BCG alone in HR-NMIBC 🔗 tinyurl.com/5n74kfv8 🍾Today makes history! 🧐Looking forward to the data in detail 🤩Happy to be part of this with my team Department of Urology, Hospital 12 De Octubre Cgdelcanizo Mario Hernández Arroyo Óscar Rodríguez Faba

⚠️For the 1st time in almost 50 years something shows superiority to #BCG alone in HR-NMIBC
🔗 tinyurl.com/5n74kfv8
🍾Today makes history!
🧐Looking forward to the data in detail
🤩Happy to be part of this with my team
<a href="/Urologia12/">Department of Urology, Hospital 12 De Octubre</a> <a href="/cgdelcanizo/">Cgdelcanizo</a> <a href="/MarioHArroyo/">Mario Hernández Arroyo</a> <a href="/RodriguezFaba/">Óscar Rodríguez Faba</a>
Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 (@cacciamani_md) 's Twitter Profile Photo

🚀 Meet the YAU UroTech Team – Innovation and digital health to bring back the joy of practicing medicine! 🔹 Digital Health Focus – Leveraging cutting-edge tech to improve patient care 💼 Reduce Workload – Smart automation to lighten the load on healthcare providers ⚙️

🚀 Meet the YAU UroTech Team – Innovation and digital health to bring back the joy of practicing medicine!

🔹 Digital Health Focus – Leveraging cutting-edge tech to improve patient care
💼 Reduce Workload – Smart automation to lighten the load on healthcare providers
⚙️